Firsthand Technology Value Fund Inc Stock Price, News & Analysis

Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) has revealed its top five investments as of February 28, 2023. The Fund's estimated total investments are approximately $42.5 million or $6.32 per share, and include cash and equivalents of $0.15 per share. Notably, IntraOp Medical leads the portfolio with about 39.3% of total investments, followed by Wrightspeed at 20.6%, Hera Systems at 18.1%, Revasum at 16.6%, and EQX Capital at 2.0%. Together, these holdings make up 96.6% of the Fund's estimated total investments. A detailed financial report is expected in May 2023.

Firsthand Technology Value Fund (SVVC) reported its fiscal year results for 2022, showing a significant decrease in net assets to approximately $30.6 million ($4.44 per share) from $94.8 million ($13.75 per share) in 2021. The portfolio includes public and private securities valued at $40.1 million ($5.82 per share). The Fund faced a total investment loss of $10.0 million and net realized and unrealized losses of $51.7 million. The management aims to enhance performance and explore exit opportunities within its portfolio.

Firsthand Technology Value Fund (NASDAQ: SVVC) has disclosed its top five holdings as of January 31, 2023. The Fund's estimated total investments were approximately $40.7 million, equating to $5.91 per share, with cash and cash equivalents of approximately $0.16 per share. The top five holdings include IntraOp Medical Corp. (42.0%), Wrightspeed, Inc. (22.0%), Hera Systems, Inc. (19.4%), Revasum, Inc. (10.7%), and EQX Capital, Inc. (2.2%), together constituting 96.2% of the Fund's investments. Quarterly financial statements will be available in May 2023.

Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $4.44 as of December 31, 2022. The fund's top five holdings include IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital, which collectively account for 125.0% of the fund's preliminary net assets. Total investments sum up to $40.1 million, equating to approximately $5.82 per share. Cash and cash equivalents are about $0.10 per share. The complete financial details will be released in the annual report due in March 2023.

Firsthand Technology Value Fund (SVVC) reported its top five investments as of October 31, 2022. These holdings represent 95.4% of the Fund's estimated total investments, valued at approximately $46.8 million or $6.78 per share, including cash equivalents of $0.13 per share. The largest investment is in IntraOp Medical (44.3%), followed by Wrightspeed (25.8%), Hera Systems (15.6%), Revasum (7.1%), and EQX Capital (2.6%). A full financial report will be published in March 2023.